Hologic, inc (HOLX)
CashFlow / Yearly
Sep'19Sep'18Sep'17Sep'16Sep'15Sep'14Sep'13Sep'12Sep'11Sep'10Sep'09Sep'08Sep'07
OPERATING ACTIVITIES
Net income (loss)

-203,600

-111,300

755,500

330,800

131,600

17,300

-1,172,800

-73,600

157,150

-62,813

-2,216,642

-415,588

94,578

Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation

92,500

101,600

89,600

82,300

81,500

94,700

95,500

71,900

68,946

68,463

67,195

52,413

14,291

Amortization of acquired intangibles

370,600

378,700

359,600

383,100

409,900

428,500

420,500

273,900

235,790

226,305

206,729

120,537

16,871

Non-cash interest expense

8,600

15,000

49,400

52,100

63,800

68,700

81,200

75,000

76,814

86,638

83,197

68,672

181

Impairment of intangible assets

-

-

-

-

-

-

-

-

-

143,467

4,065

2,900

0

Stock-based compensation expense

62,000

65,000

68,200

65,400

59,300

50,000

52,300

40,600

35,472

34,160

32,939

25,664

6,104

Excess tax benefit related to equity awards

-

-

-

-

-

5,700

7,400

6,200

3,652

2,043

2,978

62,740

21,926

Deferred income taxes

-235,700

-477,300

-357,200

-155,800

-148,800

-243,100

-198,000

-155,200

-48,107

-121,726

-26,991

-28,525

5,873

Goodwill impairment charge

0

685,700

0

0

-

-

1,117,400

5,800

-

76,723

2,340,023

-

0

Impairment of intangible assets and equipment

685,400

46,000

0

0

-

-

-

-

-

-

-

-

-

Fair value adjustments to contingent consideration

-

-

-

-

-

-

11,300

38,500

-8,016

0

-

-

-

Fair value write-up of inventory sold

7,100

1,100

39,700

0

0

-

52,400

19,900

3,298

732

1,167

46,258

0

Intangible asset and equipment impairment charges

-

-

-

-

-

38,400

9,400

16,900

-

0

-

-

-

Gain (Loss) on Disposition of Intangible Assets

-

-

-

-

-

-

53,900

12,400

84,502

0

0

-

-

Acquired in-process research and development

-

-

-

-

-

-

-

4,500

-

-

-

565,200

0

Debt extinguishment losses

-800

-45,900

-3,200

-5,300

-62,700

-7,400

-9,200

-42,300

-29,891

0

-

-

-

Payment of additional acquisition consideration

-

-

-

-

-

-

16,800

9,800

19,660

0

229

24,394

19,033

Purchases of marketable securities

-

-

-

-

-

-

-

-

-

-

-

263

0

(Gain) loss on sale of businesses

-

-

-

-

9,600

10,100

85,100

0

-

-1,035

-

-

-

Gain on sale of cost-method equity investment

-

-

-

-

-

-

-

0

-

-

-

-

-

Loss on disposal of property and equipment

-

-

-

-

-

-7,100

-4,900

-3,800

-2,639

-3,765

-4,430

-1,740

734

Gain on sale of business

0

0

899,700

0

-

-5,500

0

0

-

-341

-

-

-

Gain on sale of investments

-

-

-

25,100

0

0

-

-

-

-

-

-

-

Other adjustments and non-cash items

-18,100

-8,700

-3,200

-3,700

-20,900

11,800

-900

3,700

-1,093

-1,008

1,660

2,510

-368

Changes in operating assets and liabilities, excluding the effect of acquisitions and dispositions:
Accounts receivable

76,500

38,200

41,500

31,800

30,300

-7,900

-4,100

11,000

17,131

20,211

-57,581

58,801

45,367

Inventories

63,000

50,600

11,600

-7,600

-43,900

44,700

-25,200

12,200

32,158

5,247

14,336

29,007

7,997

Prepaid income taxes

3,200

9,400

8,700

-4,700

-700

-22,400

-25,100

-6,100

6,154

3,772

-17,925

-74,408

0

Prepaid expenses and other assets

6,000

4,200

2,400

4,900

-5,700

-17,300

-900

-69,800

471

254

577

5,662

-269

Accounts payable

-5,500

23,900

-10,600

40,100

25,500

11,800

-6,400

3,800

2,589

7,151

-12,881

-10,189

14,265

Accrued expenses and other liabilities

-16,500

53,800

-17,800

45,600

36,900

14,700

2,300

-41,000

40,569

-348

-10,613

-14,596

59,758

Deferred revenue

14,400

-1,500

-10,600

-4,900

16,100

15,100

13,300

12,700

-481

21,273

19,640

27,022

16,661

Net cash provided by operating activities

649,500

732,900

8,300

798,200

796,800

508,400

493,800

370,200

456,024

456,712

550,456

362,216

153,927

INVESTING ACTIVITIES
Acquisition of businesses, net of cash acquired

110,600

76,500

1,558,100

0

0

-

6,300

3,762,400

198,744

84,322

-

2,584,947

9,793

Equity investment impairment charges

-

-

-

-

7,800

6,900

6,400

0

2,445

1,100

2,243

-

0

Proceeds from sales and maturities of marketable securities

-

-

-

-

-

-

-

-

-

-

-

2,638

0

Proceeds From Sale Of Business

0

0

1,865,000

0

0

-

-

-

2,267

-

-

-

-

Payments to Acquire Equity Method Investments

18,200

0

0

-

-

-

-

-

-

-

-

-

-

Loans to SSI

28,400

0

0

-

-

-

-

-

-

-

-

-

-

Deferred gain

-

-

-

-

-

-

-

-

-

-

-

9,500

0

Capital expenditures

57,000

58,400

57,800

47,300

48,100

44,300

49,000

33,100

27,785

28,010

31,357

53,536

22,840

Increase in equipment under customer usage agreements

52,100

47,200

49,800

47,200

41,300

35,900

41,100

45,600

27,878

18,648

26,877

25,349

0

Proceeds from sale of available-for-sale marketable securities

0

0

87,100

31,100

0

0

-

-

-

-

-

-

-

Purchase of cost method investment

3,000

6,000

0

0

-

29,700

0

0

-

-

-

-

-

Purchases of insurance contracts

-

-

-

5,200

6,400

-13,800

4,000

0

5,322

5,322

5,322

3,322

3,322

Sales of mutual funds

-

-

-

5,200

10,000

22,400

0

0

-

-

-

-

-

Proceeds from sale of building

-

-

-

-

-

-

-

-

-

-

-

-

1,427

Payments to Acquire in Process Research and Development

4,500

0

0

-

0

0

-

4,500

-

2,000

-

-

-

Purchase of intellectual property

-

-

-

-

-

-

-

-

3,021

500

6,238

-

0

Proceeds from sale of intellectual property

-

-

-

-

-

-

60,000

12,500

13,250

73,000

2,250

3,000

0

Proceeds from sale of cost method investment

-

-

-

-

-

-

-

-

-

678

-

-

-

Purchase of cost-method equity investments

-

-

-

-

-

-

-

300

99

795

550

-

1,000

(Purchase) sale of a cost-method equity investment

-

-

-

-

-

-

-1,600

0

-

-

-

936

2,150

Other activity

6,900

7,100

600

5,000

300

3,400

7,500

7,600

-405

0

-

-

-

(Increase) decrease in restricted cash

-

-

-

-

-

-

-

-

-

26

-2,713

1,332

0

Increase in other assets

6,900

7,100

600

5,000

300

-

-

-

-

0

-

-

-

Acquisition of non-controlling interest

-

-

-

-

-

-

-

-

-

-

-

-

1,100

Other

-

-

-

-

-

-

-

-

-

-

-

-

6,393

Net cash provided by (used in) investing activities

-280,700

-195,200

285,800

-68,400

-86,100

-67,000

18,800

-3,850,800

-266,587

-66,980

-65,610

-2,677,069

-59,904

FINANCING ACTIVITIES
Proceeds from long-term debt

1,500,000

1,500,000

0

0

2,495,100

0

0

3,476,300

-

0

-

-

-

Repayment of long-term debt

1,462,500

1,359,400

84,400

75,000

3,095,000

595,000

265,000

0

1,362

177,004

-

-

-

Proceeds from Senior Notes

0

1,350,000

0

0

-

-

-

-

-

-

-

2,062

6,889

Repayment of Senior Notes

0

1,037,700

0

0

-

-

-

-

-

-

10,127

2,895

5,884

Payments to extinguish convertible notes

0

546,200

396,200

392,800

543,700

0

0

-

-

-

-

-

-

Repayment of acquired debt

2,500

3,300

0

0

-

-

-

-

-

-

-

-

-

Proceeds from revolving credit line

480,000

1,150,000

345,000

50,000

358,000

0

0

-

-

-

-

2,855,609

0

Repayments under revolving credit line

780,000

1,195,000

0

225,000

183,000

0

0

-

-

-

290,833

2,425,000

55,000

Proceeds from accounts receivable securitization agreement

43,000

34,000

48,000

200,000

0

0

-

-

-

-

-

-

-

Repayments of Accounts Receivable Securitization

34,000

9,000

48,000

0

0

-

-

-

-

-

-

-

-

Proceeds from issuance of convertible notes, net of issuance costs

-

-

-

-

-

-

-

-

-

-

-

1,688,974

0

Payments upon conversion of Cytyc convertible notes

-

-

-

-

-

-

-

-

-

-

298

40,574

0

Payment of contingent consideration

-

-

-

-

-

-

43,000

51,700

4,294

0

-

-

-

Payments to Noncontrolling Interests

-

-

-

-

-

-

-

-

-

2,684

-

-

-

Payment of deferred acquisition consideration

6,500

0

0

-

-

5,000

1,600

44,200

-

0

-

-

-

Payment of debt issuance costs

2,700

23,500

0

0

22,700

2,400

9,400

81,400

5,327

0

350

-

-

Repurchase of common stock

200,100

275,800

200,100

250,000

0

0

-

-

-

-

-

-

969

Interest Rate Cap Agreements Aggregate Premium Payable

1,500

3,700

1,900

0

13,200

0

0

-

-

-

-

-

-

Proceeds from issuance of common stock pursuant to employee stock plans

49,800

33,200

49,000

38,500

70,000

81,400

75,100

28,600

25,404

12,594

10,887

171,014

10,578

Payments under finance lease obligations

1,700

1,700

900

0

0

-

-

-

-

-

-

-

-

Excess tax benefit related to equity awards

-

-

-

-

-

5,700

7,400

6,200

3,652

2,043

2,978

62,740

21,926

Financing costs on credit agreement

-

-

-

-

-

-

-

-

-

-

-

-

0

Payment of minimum tax withholdings on net share settlements of equity awards

12,800

16,700

19,700

16,400

12,900

9,800

12,300

5,700

10,399

2,524

881

851

0

Net cash used in financing activities

-431,500

-404,800

-309,200

-670,700

-947,400

-525,100

-248,800

3,328,100

7,674

-167,575

-288,624

2,311,079

-22,460

Effect of exchange rate changes on cash and cash equivalents

-2,200

-6,800

7,300

-2,000

-8,100

-2,700

-1,700

600

-404

282

1,303

-968

-1,083

Net increase (decrease) in cash and cash equivalents

-64,900

126,100

-7,800

57,100

-244,800

-86,400

262,100

-151,900

196,707

222,439

197,525

-4,742

70,480

Supplemental disclosure of cash flow information:
Cash paid for interest

-

-

-

-

-

-

-

-

-

39,382

-

-

-